Abstract
Arylidene barbiturates 2-19 have been synthesized and their antioxidant and cytotoxic potentials have been evaluated. These compounds showed a moderate to excellent antioxidant activity in relevant antioxidant assay with no toxicity. A structure-activity relationship has been discussed. All the compounds were fully characterized by spectroscopic techniques.
Keywords: Barbiturates, DPPH, Antioxidant, Cytotoxic, Diseases
Letters in Drug Design & Discovery
Title: Synthesis of 5-Arylidene Barbiturates: A Novel Class of DPPH Radical Scavengers
Volume: 5 Issue: 4
Author(s): Khalid M. Khan, Muhammad Ali, Asma Ajaz, Shahnaz Perveen, M. Iqbal Choudhary and Atta-ur-Rahman
Affiliation:
Keywords: Barbiturates, DPPH, Antioxidant, Cytotoxic, Diseases
Abstract: Arylidene barbiturates 2-19 have been synthesized and their antioxidant and cytotoxic potentials have been evaluated. These compounds showed a moderate to excellent antioxidant activity in relevant antioxidant assay with no toxicity. A structure-activity relationship has been discussed. All the compounds were fully characterized by spectroscopic techniques.
Export Options
About this article
Cite this article as:
Khan M. Khalid, Ali Muhammad, Ajaz Asma, Perveen Shahnaz, Choudhary Iqbal M. and Atta-ur-Rahman , Synthesis of 5-Arylidene Barbiturates: A Novel Class of DPPH Radical Scavengers, Letters in Drug Design & Discovery 2008; 5 (4) . https://dx.doi.org/10.2174/157018008784619889
DOI https://dx.doi.org/10.2174/157018008784619889 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Facing Up the ROS Labyrinth - Where To Go?
Current Vascular Pharmacology Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action
Current Medicinal Chemistry Thyroid Hormones and Cardiovascular System: From Bench to Bedside
Current Drug Therapy Promotion of Insulin-Like Growth Factor-I Production by Sensory Neuron Stimulation; Molecular Mechanism(s) and Therapeutic Implications
Current Medicinal Chemistry Airway Management During Pediatric Resuscitation
Current Pediatric Reviews Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects
Current Cancer Drug Targets Prophylactic Neuroprotection
Current Drug Targets <i>Achillea millefolium</i> E.Mey: Phytochemistry and Pharmacological Profile
Current Traditional Medicine From Physiome to Pathome: A Systems Biology Model of Major Depressive Disorder and the Psycho-Immune-Neuroendocrine Network
Current Psychiatry Reviews Nitric Oxide in Atherosclerosis
Mini-Reviews in Medicinal Chemistry Antidote Control of Aptamer Therapeutics: The Road to a Safer Class of Drug Agents
Current Pharmaceutical Biotechnology A Proposal----The Renal Kallikrein-Kinin System as a Compensating System for Salt Accumulation after Excess Salt Intake
Current Hypertension Reviews Immunosuppressive Therapy for Myelodysplastic Syndromes
Current Pharmaceutical Design Progress in Syntheses of 3-n-Butylphthalide and Its Analogues
Current Organic Chemistry Sudden Infant Death Syndrome: Implications of Altered Physiological Control During Sleep
Current Pediatric Reviews Recent Progress in the Development of Adenosine Receptor Ligands as Antiinflammatory Drugs
Current Topics in Medicinal Chemistry Non-Analgesic Effects of Opioids: Neuroprotection in the Retina
Current Pharmaceutical Design Functional Selectivity in Cannabinoid Signaling
Current Molecular Pharmacology Redefining the Role of Long-Acting Phosphodiesterase Inhibitor Tadalafil in the Treatment of Diabetic Erectile Dysfunction
Current Diabetes Reviews Endothelin-Converting Enzyme Inhibitors
Current Enzyme Inhibition